Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
A:--
F: --
A:--
F: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
A:--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
--
F: --
P: --
No matching data
Latest Views
Latest Views
Trending Topics
To quickly learn market dynamics and follow market focuses in 15 min.
In the world of mankind, there will not be a statement without any position, nor a remark without any purpose.
Inflation, exchange rates, and the economy shape the policy decisions of central banks; the attitudes and words of central bank officials also influence the actions of market traders.
Money makes the world go round and currency is a permanent commodity. The forex market is full of surprises and expectations.
Top Columnists
Enjoy exciting activities, right here at FastBull.
The latest breaking news and the global financial events.
I have 5 years of experience in financial analysis, especially in aspects of macro developments and medium and long-term trend judgment. My focus is maily on the developments of the Middle East, emerging markets, coal, wheat and other agricultural products.
BeingTrader chief Trading Coach & Speaker, 8+ years of experience in the forex market trading mainly XAUUSD, EUR/USD, GBP/USD, USD/JPY, and Crude Oil. A confident trader and analyst who aims to explore various opportunities and guide investors in the market. As an analyst I am looking to enhance the trader’s experience by supporting them with sufficient data and signals.
Latest Update
Risk Warning on Trading HK Stocks
Despite Hong Kong's robust legal and regulatory framework, its stock market still faces unique risks and challenges, such as currency fluctuations due to the Hong Kong dollar's peg to the US dollar and the impact of mainland China's policy changes and economic conditions on Hong Kong stocks.
HK Stock Trading Fees and Taxation
Trading costs in the Hong Kong stock market include transaction fees, stamp duty, settlement charges, and currency conversion fees for foreign investors. Additionally, taxes may apply based on local regulations.
HK Non-Essential Consumer Goods Industry
The Hong Kong stock market encompasses non-essential consumption sectors like automotive, education, tourism, catering, and apparel. Of the 643 listed companies, 35% are mainland Chinese, making up 65% of the total market capitalization. Thus, it's heavily influenced by the Chinese economy.
HK Real Estate Industry
In recent years, the real estate and construction sector's share in the Hong Kong stock index has notably decreased. Nevertheless, as of 2022, it retains around 10% market share, covering real estate development, construction engineering, investment, and property management.
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
View All
No data
Not Logged In
Log in to access more features
FastBull Membership
Not yet
Purchase
Log In
Sign Up
Hongkong, China
Ho Chi Minh, Vietnam
Dubai, UAE
Lagos, Nigeria
Cairo, Egypt
White Label
Data API
Web Plug-ins
Affiliate Program
U.S. stocks traded mixed toward the end of trading, with the S&P 500 gaining around 0.2% on Tuesday.
The Dow traded up 0.01% to 41,242.33 while the NASDAQ rose 0.24% to 17,768.84. The S&P 500 also rose, gaining, 0.20% to 5,628.04.
Check This Out: Jim Cramer Believes In Dell CEO, Doesn’t Like B&G Foods
Leading and Lagging Sectors
Information technology shares climbed by 0.7% on Tuesday.
In trading on Tuesday, energy shares fell by 1%.
Top Headline
The S&P CoreLogic Case-Shiller home price index climbed by 6.5% year-over-year in June compared to a revised 6.9% rise in the prior month.
Equities Trading UP
Equities Trading DOWN
Commodities
In commodity news, oil traded down 2.2% to $75.69 while gold traded up 0.1% at $2,556.30.
Silver traded up 0.1% to $30.05 on Tuesday, while copper rose 0.5% to $4.3035.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.16%, Germany's DAX rose 0.35% and France's CAC 40 fell 0.32%. Spain's IBEX 35 Index rose 0.55%, while London's FTSE 100 rose 0.21%.
German economy contracted by 0.1% quarter-over-quarter in the second quarter, following a 0.2% growth in the first quarter. The GfK Consumer Climate Indicator for Germany fell to a reading of -22.0 heading into September compared to a revised -18.6 in the prior period.
Asia Pacific Markets
Asian markets closed mostly higher on Tuesday, with Japan's Nikkei 225 gaining 0.47%, Hong Kong's Hang Seng Index gaining 0.43%, China's Shanghai Composite Index falling 0.24% and India's BSE Sensex rising 0.02%.
Hong Kong’s trade deficit narrowed to $21.8 billion in July versus a $30 billion gap in the year-ago month, as exports increased more than imports.
Economics
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling around 0.2% on Tuesday.
The Dow traded down 0.16% to 41,175.13 while the NASDAQ fell 0.03% to 17,720.68. The S&P 500 also fell, dropping, 0.01% to 5,616.66.
Check This Out: Jim Cramer Believes In Dell CEO, Doesn’t Like B&G Foods
Leading and Lagging Sectors
Information technology shares climbed by 0.5% on Tuesday.
In trading on Tuesday, energy shares fell by 0.6%.
Top Headline
Hain Celestial Group, Inc. reported better-than-expected quarterly results on Tuesday.
The company reported fourth quarter adjusted earnings per share of 13 cents, beating the analyst consensus estimate of 8 cents. Quarterly revenues of $418.80 million missed the street view of $421.2 million.
Equities Trading UP
Equities Trading DOWN
Commodities
In commodity news, oil traded down 1.8% to $76.02 while gold traded down 0.2% at $2,550.90.
Silver traded down 0.1% to $29.97 on Tuesday, while copper rose 0.6% to $4.3085.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.17%, Germany's DAX rose 0.40% and France's CAC 40 fell 0.17%. Spain's IBEX 35 Index rose 0.40%, while London's FTSE 100 rose 0.28%.
German economy contracted by 0.1% quarter-over-quarter in the second quarter, following a 0.2% growth in the first quarter. The GfK Consumer Climate Indicator for Germany fell to a reading of -22.0 heading into September compared to a revised -18.6 in the prior period.
Asia Pacific Markets
Asian markets closed mostly higher on Tuesday, with Japan's Nikkei 225 gaining 0.47%, Hong Kong's Hang Seng Index gaining 0.43%, China's Shanghai Composite Index falling 0.24% and India's BSE Sensex rising 0.02%.
Hong Kong’s trade deficit narrowed to $21.8 billion in July versus a $30 billion gap in the year-ago month, as exports increased more than imports.
Economics
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
U.S. stocks traded mixed this morning, with the Dow Jones index gaining over 50 points on Tuesday.
Following the market opening Tuesday, the Dow traded up 0.16% to 41,240.52 while the NASDAQ fell 0.42% to 17,651.68. The S&P 500 also fell, dropping, 0.22% to 5,604.73.
Check This Out: Jim Cramer Believes In Dell CEO, Doesn’t Like B&G Foods
Leading and Lagging Sectors
Health care shares climbed by 0.2% on Tuesday.
In trading on Tuesday, information technology shares fell by 0.6%.
Top Headline
ScanSource, Inc. reported worse-than-expected fourth-quarter financial results.
ScanSource reported quarterly earnings of 80 cents per share which missed the analyst consensus estimate of 93 cents per share. The company reported quarterly sales of $746.113 million which missed the analyst consensus estimate of $843.143 million.
ScanSource said it sees FY25 revenues of $3.1 billion to $3.5 billion, versus estimates of $3.47 billion.
Equities Trading UP
Equities Trading DOWN
Commodities
In commodity news, oil traded down 1% to $76.67 while gold traded down 0.4% at $2,545.10.
Silver traded down 0.3% to $29.92 on Tuesday, while copper rose 0.3% to $4.2915.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.1%, Germany's DAX rose 0.4% and France's CAC 40 fell 0.2%. Spain's IBEX 35 Index rose 0.2%, while London's FTSE 100 rose 0.2%.
German economy contracted by 0.1% quarter-over-quarter in the second quarter, following a 0.2% growth in the first quarter. The GfK Consumer Climate Indicator for Germany fell to a reading of -22.0 heading into September compared to a revised -18.6 in the prior period.
Asia Pacific Markets
Asian markets closed mostly higher on Tuesday, with Japan's Nikkei 225 gaining 0.47%, Hong Kong's Hang Seng Index gaining 0.43%, China's Shanghai Composite Index falling 0.24% and India's BSE Sensex rising 0.02%.
Hong Kong’s trade deficit narrowed to $21.8 billion in July versus a $30 billion gap in the year-ago month, as exports increased more than imports.
Economics
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Tuesday, Addex Therapeutics Ltd stock is trading higher with a session volume of 3.79 million versus the average volume of 4.16K as per data from Benzinga Pro.
Addex Therapeutics and Indivior PLC announced that they have selected clinical candidates from their GABAB-positive allosteric modulator (PAM) research collaboration.
Indivior has selected a compound for future development in substance use disorder and will now undertake all future development of their selected compound.
Under the terms of the agreement, Addex is eligible for payment of up to $330 million on achievement of prespecified regulatory, clinical and commercial milestones as well as tiered royalties on the level of net sales from high single digits up to low double-digit.
Under the terms of the agreement, Addex has also exercised its right to select a compound to advance its own independent GABAB PAM program for chronic cough.
“Indivior’s collaboration with Addex has been instrumental in identifying a possible candidate for the treatment of substance use disorders,” said Christian Heidbreder, Chief Scientific Officer at Indivior.”
“The selection of GABAB PAM clinical candidates is the culmination of more than five years of research at Addex in close collaboration with the team at Indivior...We look forward to the next steps in the development of the substance use disorder program under the control of Indivior,” said Tim Dyer, CEO of Addex. “On the Addex side, we are now focused on advancing our selected clinical candidate for chronic cough into IND-enabling studies.”
In July, Addex Therapeutics announced that its partner Janssen Pharmaceuticals, Inc., a unit of Johnson & Johnson , discontinued the development of ADX71149 (JNJ-40411813) in epilepsy.
The decision follows top-line Phase 2 data announced in April, showing that adjunctive ADX71149 (JNJ-40411813) administration in patients with focal onset seizures with suboptimal response to levetiracetam or brivaracetam did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was added to standard of care.
Price Action: ADXN stock is 63.2% at $12.50 during the premarket session at last check Tuesday.
Read Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.